A double-blind placebo-controlled trial of azithromycin to reduce mortality and improve growth in high-risk young children with non-bloody diarrhoea in low resource settings: The Antibiotics for Children with Diarrhoea (ABCD) trial protocol

T. Alam, D. Ahmed, T. Ahmed, M. J. Chisti, M. W. Rahman, A. K. Asthana, P. K. Bansal, A. Chouhan, S. Deb, P. Dhingra, U. Dhingra, A. Dutta, V. K. Jaiswal, J. Kumar, A. Pandey, S. Sazawal, A. K. Sharma, C. McGrath, C. Nyabinda, M. OkelloP. B. Pavlinac, B. Singa, J. L. Walson, N. Bar-Zeev, Q. Dube, B. Freyne, C. Ndamala, L. Ndeketa, H. Badji, J. P. Booth, F. Coulibaly, F. Haidara, K. Kotloff, D. Malle, A. Mehta, S. Sow, M. Tapia, S. Tennant, A. Hotwani, F. Kabir, F. Qamar, S. Qureshi, S. Shakoor, R. Thobani, M. T. Yousufzai, M. Bakari, C. Duggan, U. Kibwana, R. Kisenge, K. Manji, S. Somji, C. Sudfeld, P. Ashorn, R. Bahl, A. De Costa, J. Simon

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A double-blind placebo-controlled trial of azithromycin to reduce mortality and improve growth in high-risk young children with non-bloody diarrhoea in low resource settings: The Antibiotics for Children with Diarrhoea (ABCD) trial protocol'. Together they form a unique fingerprint.

Medicine & Life Sciences